Results Through Rehabilitation & Research
As a leader in rehabilitation research striving to make scientific discoveries that will better the lives of those suffering from disability stemming from injury or illness, Burke Rehabilitation Hospital and Burke Medical Research Institute conduct ongoing basic, translational and clinical research. From time-to-time, Burke will recruit subjects its clinical trials. If you are interested in being part of a study, bookmark this page and check it occasionally for trials in need of subjects.
Below are Burke's medical research studies currently enrolling participants.
Burke Medical Research Institute is currently looking for spinal cord injury patients for three different clinical studies. If you are interested in learning more and fit in one of the patient criteria below, please contact Mar Cortes, M.D., at email@example.com or (914) 368-3181.
Patient Population Needed:
If you are over the age of 18, have difficulty moving your legs, and are taking Baclofen IR, you may be eligible for participation.
All patients will receive study medication and study-related care with a physician at no cost. Compensation for travel expenses is available.
To learn more contact Rosanna Cirio at (914) 597-2476.
The Burke-Cornell Early Brain Injury Recovery Program is currently recruiting children with hemiplegia (weakness on one side of the body) for clinical trials involving high intensity hand therapy and non-invasive brain stimulation.
Children ages 1-18 are eligible. For more information, please e-mail the clinic.
Burke Rehabilitation Hospital is currently seeking patients who have had an ischemic stroke and continue to have problems with sensorimotor abilities to evaluate the effects of dalfampridine on motor recovery. Dalfampridine (known under the trademark AMPYRA® of Acorda Therapeutics, Inc.) has been approved by the U.S. Food and Drug Administration (FDA) for patients with multiple sclerosis to help improve their ability to walk, but has not been studied in patients recovering from an ischemic stroke.
Pasquale Fonzetti, M.D., Ph.D., staff neurologist and associate director of Memory Evaluation and Treatment Service (METS) at Burke Rehabilitation Hospital and assistant professor of neurology at Weill Cornell Medical College, is the principal investigator for this study.
To pre-qualify for this study, you must:
All study-related visits, tests and study drugs will be provided at no cost. Compensation for time and travel may also be provided.
For more information about this study, please contact Diana Zondorak, Ph.D., clinical coordinator, at (914) 597-2827.